How to Scale GLP-1 Distribution Without Losing Control

Article

GLP-1 Growth Challenges Supply Chains

GLP-1 therapies are now a major operational priority. They impact pharmacies, health systems, and distributors. Rising demand for diabetes and weight management care strains supply. It also affects device handling and patient access. Manufacturers are increasing production. More injectable therapies will continue entering the market.

Pharmacy leaders must focus on safe operations. They need to handle high-demand injectables without creating risks. A standard model may fail during shortages. It can also struggle when cold storage reaches capacity. It often fails when patients need urgent replacements.

A scalable system requires coordination. Teams must align procurement, inventory, and pharmacy operations. They must also manage patient support and transportation. OnWay Transport helps design time-sensitive workflows. These support access while maintaining chain-of-custody visibility.

Understanding Injectable GLP-1 Profiles

GLP-1 products often use prefilled pens or devices. This differs from standard oral medication delivery. The drug, the device, and the instructions must all arrive safely. Pharmacy teams must follow FDA-approved labels and manufacturer handling instructions for every specific item.

Consider these important operational characteristics:

Temperature sensitivity: Many injectables require refrigeration. Excursions can affect the product. Never guess about safe time limits outside refrigeration. Always follow product-specific guidance.

High-value inventory: Shortages make these items expensive and hard to replace. Inventory loss impacts patient care and finances.

Device integrity: Pens are engineered tools. Freezing, crushing, or vibrations can break them. The medication might appear fine, but the device could fail.

Refill patterns: Patients require consistent monthly fulfillment. Missed windows lead to interrupted therapy. This increases the workload for pharmacy staff.

Variable allocation: Manufacturers or wholesalers may limit product availability. This can be based on geography or history. Pharmacy procurement needs a formal plan to manage these constraints.

GLP-1 distribution is a cross-functional effort. Involve purchasing, finance, IT, and transportation early. Do not treat home delivery as a simple courier task.

Building a Handling and Temperature Program

Cold-chain discipline starts before a package leaves the pharmacy. Map the journey from dock to final delivery. Document all storage points and responsible parties. Include temperature ranges and transit limits. Define the process for handling suspected temperature excursions.

USP does not provide a single shipping rule for all refrigerated drugs. However, USP <1079> Good Storage and Distribution Practices for Drug Products is a strong framework. Use it to manage temperature through documented training and monitoring. Pair this framework with manufacturer requirements.

Use these practical controls:

Conditioned packaging and validated coolants

Tamper-evident seals

Route-duration thresholds

Delivery-time planning

Documented proof of delivery

For high-risk items, use temperature monitors or data loggers. The level of monitoring should match the product risk. Do not confuse insulation with a validated cold chain. A box can look professional but fail if it sits in a hot vehicle. Measure real-world conditions to improve your standards.

Using Allocation Governance to Protect Access

Supply shortages cause inconsistency and patient frustration. Establish an allocation process before shortages worsen. Define who approves inventory transfers. Create policies for substitutions and backorder communications. Determine which patients receive priority.

Clinical teams should drive therapeutic decisions. Supply chain teams provide the necessary data. Useful metrics include days of stock on hand and wholesaler fill rates. Hold weekly cross-functional meetings. This helps identify problems before they reach the patient.

Communicate clearly with patients. They should not learn of delays after a failed delivery. Staff need standard scripts to explain the situation professionally.

Separating Visibility from Eligibility

Inventory visibility shows if a drug is available. Eligibility decisions determine who receives limited supply. Keep these functions separate. Avoid managing these through ad hoc spreadsheets. Maintain clear ownership between supply chain and clinical teams.

Designing Last-Mile Delivery

Last-mile delivery is where pharmacy processes often break down. Packages can face missed handoffs or weather exposure. Refrigerated drugs are at risk if left unattended. Segment your delivery options based on risk levels.

Same-day delivery: Use for patients needing rapid replacement or those unable to visit.

Next-day delivery: Use for stable lanes with validated packaging.

Pickup: Offer this for patients needing direct handoff or residing in high-risk areas.

OnWay Transport provides scheduled medical deliveries. We offer chain-of-custody documentation and real-time visibility. Our goal is a repeatable workflow with fewer exceptions.

Establish a protocol for failed deliveries. It should cover return-to-pharmacy procedures and security. Define when a pharmacist must inspect a returned package.

Protecting Patient Information

GLP-1 deliveries involve protected health information. Labels and manifests can reveal patient data. HIPAA requires administrative and technical safeguards. Use the minimum necessary information for dispatch. Limit access to delivery records. Train staff on privacy expectations.

Select technology vendors that support compliance. Notifications should be useful without disclosing diagnoses. Proof-of-delivery records should only collect required data. Privacy builds trust and ensures compliance.

Measuring Risk Metrics

Manage programs with a concise operational scorecard. Focus on these key measures:

On-time delivery rates by geography

First-attempt success rates

Temperature excursion or deviation rates

Returned shipment frequency

Days of inventory on hand

Backorder duration

Product loss from expiration or damage

Patient complaint and refill interruption rates

Review specific exceptions, not just broad averages. Patterns of failure in specific areas reveal where to adjust routing or packaging.

Scaling Through Partnerships

The demand for injectable therapies will continue to test supply chains. Do not rely on manual workarounds that cannot scale. Develop standard handling procedures and allocation rules. Build patient-centered delivery designs with measurable quality controls.

Resilient models connect pharmacy operations to a healthcare-focused partner. OnWay Transport provides customized solutions. We prioritize the urgency and visibility required for healthcare logistics.

Key Takeaways

• GLP-1 fulfillment requires coordinated inventory, cold-chain, pharmacy, and delivery controls.
• Product-specific manufacturer guidance should drive storage, packaging, and excursion decisions.
• Allocation governance helps protect patient access during supply constraints.
• Last-mile delivery performance must be measured through handoff, temperature, and exception data.

Frequently Asked Questions

How are GLP-1 medications shipped to patients?

GLP-1 medications are commonly shipped using product-specific temperature-controlled packaging, secure labeling, and delivery methods designed to protect the medication until handoff. Pharmacies should follow the manufacturer’s current storage instructions and use documented procedures for delays, failed deliveries, and suspected temperature excursions.

Do GLP-1 medications need to be refrigerated during delivery?

Many GLP-1 products require refrigeration before dispensing, but shipping requirements differ by product and package configuration. Pharmacies should use the approved prescribing information and manufacturer guidance to determine allowable temperature ranges, transit times, and packaging requirements.

How can pharmacies prevent GLP-1 delivery failures?

Pharmacies can reduce failures by confirming patient availability, offering scheduled delivery windows, using chain-of-custody proof of delivery, and maintaining a documented return process. Reviewing failed-delivery reasons by route and patient location also helps identify recurring issues.

More from our resource library

• How to Choose a Medical Courier Company
• Hurricane Season Contingency Plans for Healthcare Logistics